机器人主动脉瓣置换术:首50例经验
本研究报道了50例全机器人辅助主动脉瓣置换术(RAVR)的早期经验,采用3-4cm侧胸小切口三孔技术及经胸主动脉阻断。患者中位年龄67.5岁,56%为钙化二叶瓣,16%为重度主动脉瓣反流。无30天手术死亡或卒中,所有患者30天超声心动图无瓣膜或瓣周异常。
要点
- RAVR采用3-4cm侧胸小切口三孔技术,经胸主动脉阻断,植入常规外科瓣膜。
- 50例中无30天手术死亡或卒中,84%在手术室拔管,其余4小时内拔管。
- 术后30天超声心动图均无瓣膜或瓣周异常,短期结果良好。
核心结论
- RAVR似乎具有与替代方案相竞争的手术安全性和短期结果。
- 随着经验积累,可能促进安全实施必要的同期手术。
研究设计与样本
- 单中心前瞻性病例系列,连续50例RAVR手术,2020年1月至2021年2月。
- 采用3-4cm侧胸小切口三孔技术,经胸主动脉阻断,植入常规外科瓣膜。
主要发现
- 患者中位年龄67.5岁,体重指数29 kg/m2,钙化二叶瓣28例(56%),重度主动脉瓣反流8例(16%)。
- 射血分数0.55±0.08,STS预测死亡风险1.54%±0.7%。
- 机械瓣使用16例(32%),7例需同期手术(Cox迷宫3例,主动脉根部扩大2例,左心耳夹闭、二尖瓣修复、左房黏液瘤切除各1例)。
- 中位体外循环时间166分钟,主动脉阻断时间117分钟,瓣膜切除4分钟,瓣环缝线20分钟,主动脉切开闭合31分钟;所有时间在最初5例后趋于稳定。
- 手术室拔管42例(84%),其余8例(16%)在4小时内拔管;无30天手术死亡或卒中;30天超声心动图均无瓣膜或瓣周异常。
临床怎么用
- 对于存在二叶瓣狭窄、低临床风险、水平瓣位、主动脉瓣反流或需同期手术/机械瓣的患者,RAVR可作为经导管与外科主动脉瓣置换的替代选择。
- 随着经验积累,可安全实施必要的同期手术。
局限性
- 早期经验,样本量小(50例),随访仅30天。
- 单中心、非随机设计,缺乏与经导管或传统外科手术的对照。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Existing management challenges in selecting transcatheter vs surgical aortic valve replacement (SAVR) include bicuspid stenosis, low clinical risk, horizontal valve position, aortic insufficiency (AI), and need for concomitant procedures or mechanical valves. To address these gaps, we present our early experience with fully robotic-assisted aortic valve replacement (RAVR). METHODS: Between January 2020 and February 2021, 50 consecutive RAVR operations were performed using a 3- to 4-cm lateral mini-thoracotomy 3-port technique with transthoracic aortic clamping, similar to our robotic mitral platform. Conventional SAVR prostheses were implanted with interrupted braided sutures in all cases. RESULTS: The 50 patients were a median age of 67.5 years, body mass index was 29 kg/m2, calcified bicuspid disease was present in 28 (56%), and severe AI in 8 (16%). Ejection fraction was 0.55 ± 0.08 (mean ± SD), and The Society of Thoracic Surgeons predicted risk of mortality was 1.54% ± 0.7%. Mechanical prostheses were used in 16 of 50 (32%), and 7 required concomitant procedures, including Cox maze in 3, aortic root enlargement in 2, and left atrial appendage clipping, mitral repair, and left atrial myxoma excision in 1 each. Median times (minutes) were 166 for cardiopulmonary bypass, 117 for cross-clamp, 4 for valvectomy, 20 for annular sutures, and 31 for aortotomy closure. All times plateaued after the initial 5 cases. Extubation occurred in 42 of 50 patients (84%) in the operating room, and within 4 hours in the remaining 8 (16%). There was no 30-day operative mortality or stroke. All had 30-day echocardiography demonstrating no valvular or perivalvular abnormalities. CONCLUSIONS: RAVR appears to have procedural safety and short-term outcomes to rival alternatives. Incremental experience may facilitate the safe performance of concomitant procedures as deemed necessary.
引用
- Wei LM, Cook CC, Hayanga JWA, et al. Robotic Aortic Valve Replacement: First 50 Cases. Ann Thorac Surg. 2021. PMID: 34560044. doi:10.1016/j.athoracsur.2021.08.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。